Mammalian iron homeostasis in health and disease: Uptake, storage, transport, and molecular mechanisms of action

Antioxidants and Redox Signaling

Volumn 18, Issue 18, 2013, Pages 2473-2507

  Lawen, Alfons ^a   Lane, Darius J R ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CCAAT ENHANCER BINDING PROTEIN ALPHA; FERRITIN; FERROPORTIN; HEMOGLOBIN; HEMOJUVELIN; HEMOPEXIN; HEPCIDIN; IRON; MYOGLOBIN; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA;

5' UNTRANSLATED REGION; BETA THALASSEMIA; BLOOD BRAIN BARRIER; CYTOPLASM; ENZYME ACTIVITY; ERYTHROPHAGOCYTOSIS; HEMOCHROMATOSIS; HUMAN; INTESTINE CELL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; MAMMAL CELL; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANEMIA; ANIMALS; BETA-THALASSEMIA; BIOLOGICAL TRANSPORT; CATION TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON; PROTEOLYSIS; TRANSFERRIN;

MAMMALIA; MUS;

EID: 84877741258     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4271     Document Type: Review

References (435)

1. Abboud S and Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912, 2000.
2. Aisen P and Listowsky I. Iron transport and storage proteins. Annu Rev Biochem 49: 357-393, 1980.
3. Aisen P, Leibman A, and Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. J Biol Chem 253: 1930-1937, 1978.
4. Anderson GJ. Ironing out disease: inherited disorders of iron homeostasis. IUBMB Life 51: 11-17, 2001.
5. Andrews NC. Forging a field: the golden age of iron biology. Blood 112: 219-230, 2008.
6. Andrews SC. The ferritin-like superfamily: evolution of the biological iron storeman from a rubrerythrin-like ancestor. Biochim Biophys Acta 1800: 691-705, 2010.
7. Andriopoulos B, Jr., Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, and Babitt JL. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41: 482-487, 2009.
8. Arndt S, Maegdefrau U, Dorn C, Schardt K, Hellerbrand C, and Bosserhoff A-K. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 138: 372-382, 2010.
9. Arosio P, Ingrassia R, and Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790: 589-599, 2008.
10. Atanassova BD and Tzatchev KN. Ascorbic acid- important for iron metabolism. Folia Med (Plovdiv) 50: 11-16, 2008.
11. Attieh ZK, Mukhopadhyay CK, Seshadri V, Tripoulas NA, and Fox PL. Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem 274: 1116-1123, 1999.
12. Attisano L and Wrana JL. Mads and Smads in TGFb signalling. Curr Opin Cell Biol 10: 188-194, 1998.
13. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, and Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539, 2006.
14. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, and Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117: 1933-1939, 2007.
15. Bailey S, Evans RW, Garratt RC, Gorinsky B, Hasnain S, Horsburgh C, Jhoti H, Lindley PF, Mydin A, Sarra R, and Watson JL. Molecular structure of serum transferrin at 3.3-A resolution. Biochemistry 27: 5804-5812, 1988.
16. Baker E, Baker SM, and Morgan EH. Characterisation of non-transferrin-bound iron (ferric citrate) uptake by rat hepatocytes in culture. Biochim Biophys Acta 1380: 21-30, 1998.
17. Baker MA and Lawen A. The function of the plasma membrane NADH-oxidoreductase system. A critical review of the structural and functional data. Antioxid Redox Signal 2: 197-212, 2000.
18. Barnham KJ and Bush AI. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 12: 222-228, 2008.
19. Béliveau F, Brulé C, Désilets A, Zimmerman B, Laporte SA, Lavoie CL, and Leduc R. Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality. J Biol Chem 286: 29035-29043, 2011.
20. Bennett MJ, Lebrón JA, and Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE com-plexed with transferrin receptor. Nature 403: 46-53, 2000.
21. Beutler E. Hemochromatosis: genetics and pathophysi-ology. Annu Rev Med 57: 331-347, 2006.
22. Beutler L and Beutler E. Hematologically important mutations: iron storage diseases. Blood Cells Mol Dis 33: 40-44, 2004.
23. Bianchi L, Tacchini L, and Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucl Acid Res 27: 4223-4227, 1999.
24. Bishop GM, Scheiber IF, Dringen R, and Robinson SR. Synergistic accumulation of iron and zinc by cultured astrocytes. J Neural Transm 117: 809-817, 2010.
25. Bishop GM, Dang TN, Dringen R, and Robinson SR. Accumulation of non-transferrin-bound iron by neuons, astrocytes, and microglia. Neurotox Res 19: 443-451, 2011.
26. Bomford A, Young SP, and Williams R. Release of iron from the two iron-binding sites of transferrin by cultured human cells: modulation by methylamine. Biochemistry 24: 3472-3478, 1985.
27. Bothwell TH. The control of iron absorption. Br J Haematol 14: 453-456, 1968.
28. Bou-Abdallah F. The iron redox and hydrolysis chemistry of the ferritins. Biochim Biophys Acta 1800: 719-731, 2010.
29. Bourdon E, Kang DK, Ghosh MC, Drake SK, Wey J, Levine RL, and Rouault TA. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2. Blood Cells Mol Dis 31: 247-255, 2003.
30. Bouton C and Drapier JC. Iron regulatory proteins as NO signal transducers. Sci STKE 2003: pe17, 2003.
31. Bradbury MWB. Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 69: 443-454, 1997.
32. Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, and Beaumont C. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 140: 1261-1271.e1, 2011.
33. Bratosin D, Mazurier J, Tissier JP, Estaquier J., Huart JJ, Ameisen JC, Aminoff D, and Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 80: 173-195, 1998.
34. Braun V and Focareta T. Pore-forming bacterial protein hemolysins (cytolysins). Crit Rev Microbiol 18: 115-158, 1991.
35. Braun V and Hantke K. Recent insights into iron import by bacteria. Curr Opin Chem Biol 15: 328-334, 2011.
36. Breuer W, Hershko C, and Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23: 185-192, 2000.
37. Breuer W, Shvartsman M, and Cabantchik ZI. Intracellular labile iron. Int J Biochem Cell Biol 40: 350-354, 2008.
38. Bullen JJ, Spalding PB, Ward CG, and Gutteridge JM. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med 151: 1606-1609, 1991.
39. Burdo JR, Antonetti DA, Wolpert EB, and Connor JR. Mchanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience 121: 883-890, 2003.
40. Burkitt MJ and Gilbert BC. Model studies of the iron-catalysed Haber-Weiss cycle and the ascorbate-driven Fenton reaction. Free Radic Res Commun 10: 265-280, 1990.
41. Cai CX and Linsenmayer TF. Nuclear translocation of ferritin in corneal epithelial cells. J Cell Sci 114: 2327-2334, 2001.
42. Cai CX, Birk DE, and Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell 9: 1037-1051, 1998.
43. Cairo G, Recalcati S, Mantovani A, and Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol 32: 241-247, 2011.
44. 2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 276: 19738-19745, 2001.
45. Calzolari A, Raggi C, Deaglio S, Sposi NM, Stafsnes M, Fecchi K, Parolini I, Malavasi F, Peschle C, Sargiacomo M, and Testa U. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J Cell Sci 119: 4486-4498, 2006.
46. Camaschella C and Silvestri L. Molecular mechanisms regulating hepcidin revealed by hepcidin disorders. Scien-tificWorldJournal 11: 1357-1366, 2011.
47. Camaschella C, Roetto A, and De Gobbi M. Juvenile he-mochromatosis. Semin Hematol 39: 242-248, 2002.
48. Campanella A, Isaya G, O'Neill HA, Santambrogio P, Cozzi A, Arosio P, and Levi S. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet 13: 2279-2288, 2004.
49. Casey JL, Koeller DM, Ramin VC, Klausner RD, and Harford JB. Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3¢ untranslated region of the mRNA. EMBO J 8: 3693-3699, 1989.
50. Cassavaugh J and Lounsbury KM. Hypoxia-mediated biological control. J Cell Biochem 112: 735-744, 2011.
51. Challis GL. A widely distributed bacterial pathway for siderophore biosynthesis independent of nonribosomal peptide synthetases. ChemBioChem 6: 601-611, 2005.
52. Chen W, Dailey HA, and Paw BH. Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis. Blood 116: 628-630, 2010.
53. Chen D, Zhao M, and Mundy GR. Bone morphogenetic proteins. Growth Factors 22: 233-241, 2004.
54. Chen J and Enns CA. The cytoplasmic domain of transfer-rin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells. J Biol Chem 282: 6201-6209, 2007.
55. Chen J, Chloupkova M, Gao J, Chapman-Arvedson TL, and Enns CA. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions. J Biol Chem 282: 36862-36870, 2007.
56. Chen W, Huang FW, de Renshaw TB, and Andrews NC. Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis. Blood 117: 6319-6325, 2011.
57. Chen L, Zhang X, Chen-Roetling J, and Regan RF. Increased striatal injury and behavioral deficits after in-tracerebral hemorrhage in hemopexin knockout mice. J Neurosurg 114: 1159-1167, 2011.
58. Chen OS, Schalinske KL, and Eisenstein RS. Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver. J Nutr 127: 238-248, 1997.
59. Cheng Y, Zak O, Aisen P, Harrison SC, and Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 116: 565-576, 2004.
60. Chepelev NL and Willmore WG. Regulation of iron pathways in response to hypoxia. Free Radic Biol Med 50: 645-666, 2011.
61. Chloupková M, Zhang A-S, and Enns CA. Stoichiometries of transferrin receptors 1 and 2 in human liver. Blood Cells Mol Dis 44: 28-33, 2010.
62. Chua AC, Graham RM, Trinder D, and Olynyk JK. The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 44: 413-459, 2007.
63. This reference has been deleted.
64. Clark NG, Sheard NF, and Kelleher JF. Treatment of iron-deficiency anemia complicated by scurvy and folic acid deficiency. Nutr Rev 50: 134-137, 1992.
65. Clark SF. Iron deficiency anemia. Nutr Clin Pract 23: 128-141, 2008.
66. Clarke SL, Vasanthakumar A, Anderson SA, Pondarre C, Koh CM, Deck KM, Pitula JS, Epstein CJ, Fleming MD, and Eisenstein RS. Iron-responsive degradation of iron-regulatory protein 1 does not require the iron-S cluster. EMBO J 25: 544-553, 2006.
67. Cmejla R, Petrak J, and Cmejlova J. A novel iron responsive element in the 3¢UTR of human MRCKa. Biochem Biophys Res Commun 341: 158-166, 2006.
68. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, and Maxwell PH. Hypoxia inducible factor-a binding and ubi-quitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275: 25733-25741, 2000.
69. Conrad ME and Umbreit JN. Iron absorption and transport: an update. Am J Hematol 64: 287-298, 2000.
70. Conrad ME, Umbreit JN, Moore EG, Hainsworth LN, Porubcin M, Simovich MJ, Nakada MT, Dolan K, and Garrick MD. Separate pathways for cellular uptake of ferric and ferrous iron. Am J Physiol 279: G767-G774, 2000.
71. Constantine CC, Anderson GJ, Vulpe CD, McLaren CE, Bahlo M, Yeap HL, Gertig DM, Osborne NJ, Bertalli NA, Beckman KB, Chen V, Matak P, McKie AT, Delatycki MB, Olynyk JK, English DR, Southey MC, Giles GG, Hopper JL, Allen KJ, and Gurrin LC. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol 147: 140-149, 2009.
72. Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, Ghosh MC, McConnell JP, and Rouault TA. Microcytic anemia, erythropoietic protoporphyria, and neurodegen-eration in mice with targeted deletion of iron-regulatory protein 2. Blood 106: 1084-1091, 2005.
73. Corradini E, Garuti C, Montosi G, Ventura P, Andriopoulos B, Jr., Lin HY, Pietrangelo A, and Babitt JL. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastro-enterology 137: 1489-1497, 2009.
74. Corradini E, Meynard D, Wu Q, Chen S, Ventura P, Pie-trangelo A, and Babitt JL. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54: 273-284, 2011.
75. Corsi B, Cozzi A, Arosio P, Drysdale J, Santambrogio P, Campanella A, Biasiotto G, Albertini A, and Levi S. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277: 22430-22437, 2002.
76. Corwin HL. The role of erythropoietin therapy in the critically ill. Transfus Med Rev 20: 27-33, 2006.
77. Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez FJ, Leroyer P, Gilot D, Boudjema K, Guguen-Guillouzo C, Brissot P, Loréal O, and Ilyin G. C/EBPa regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 277: 41163-41170, 2002.
78. Cox EV, Meynell MJ, Northam BE, and Cooke WT. The anaemia of scurvy. Am J Med 42: 220-227, 1967.
79. Cox TC, Bawden MI, Martin A, and May BK. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron responsive element in the mRNA. EMBO J 10: 1891-1902, 1991.
80. Crane FL and Löw H. NADH oxidation in liver and fat cell plasma membranes. FEBS Lett 68: 153-156, 1976.
81. Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, and Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypo-transferrinemic mouse: a rodent model for hemochroma-tosis. Proc Natl Acad Sci U S A 84: 3457-3461, 1987.
82. Dassler K, Zydek M, Wanzik K, Kaup M, and Fuchs H. Release of the soluble transferrin receptor is directly regulated by binding of its ligand ferritransferrin. J Biol Chem 281: 3297-3304.
83. De Domenico I, McVey Ward D, and Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9: 72-81, 2008.
84. De Domenico I, Ward DM, Musci G, and Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 91: 92-95, 2006.
85. De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, and Kaplan J. The molecular basis of ferro-portin-linked hemochromatosis. Proc Natl Acad Sci U S A 102: 8955-8960, 2005.
86. De Domenico I, Ward DM, Musci G, and Kaplan J. Evidence for the multimeric structure of ferroportin. Blood 109: 2205-2209, 2007.
87. De Silva DM, Askwith CC, and Kaplan J. Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev 76: 31-47, 1996.
88. Deane R, Zheng W, and Zlokovic BV. Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J Neurochem 88: 813-820, 2004.
89. Del Principe D, Avigliano L, Savini I, and Catani MV. Trans-plasma membrane electron transport in mammals: Functional significance in health and disease. Antioxid Redox Signal 14: 2289-2318, 2011.
90. Derbyshire ER and Marletta MA. Biochemistry of soluble guanylate cyclase. Handb Exp Pharmacol 191: 17-31, 2009.
91. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, and Zon LI. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781, 2000.
92. Double KL, Maywald M, Schmittel M, Riederer P, and Gerlach M. In vitro studies of ferritin iron release and neurotoxicity. J Neurochem 70: 2492-2499, 1998.
93. Dringen R, Bishop GM, Koeppe M, Dang TN, and Robinson SR. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32: 1884-1890, 2000.
94. Dringen R, Bishop GM, Koeppe M, Dang TN, and Robinson SR. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32: 1884-1890, 2007.
95. Drysdale J, Arosio P, Invernizzi R, Cazzola M, Volz A, Corsi B, Biasiotto G, and Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol Dis 29: 376-383, 2002.
96. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, Khovananth K, Mudd S, Mann N, Moresco EMY, Beutler E, and Beutler B. The serine protease TMPRSS6 is required to sense iron deficiency. Science 320: 1088-1092, 2008.
97. Eastham EJ, Bell JI, and Douglas AP. Iron-transport characteristics of vesicles of brush-border and basolateral plasma membrane from the rat enterocyte. Biochem J 164: 289-294, 1977.
98. Enns CA, Suomalainen HA, Gebhardt JE, Schröder J, and Sussman HH. Human transferrin receptor: expression of the receptor is assigned to chromosome 3. Proc Natl Acad Sci U S A 79: 3241-3245, 1982.
99. Erlandsen H, Patch MG, Gamez A, Straub M, and Stevens RC. Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenyl-ketonuria. Pediatrics 112: 1557-1565.
100. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, and Cabantchik ZI. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102: 2670-2677, 2003.
101. Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw J-J, Agid Y, and Hirsch EC. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci U S A 92: 9603-9607, 1995.
102. Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, and Schatzman RC. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 95: 1472-1477, 1998.
103. 2-microglobulin interaction and cell surface expression. J Biol Chem 272: 14025-14028, 1997.
104. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65: 899-910, 1894.
105. Fillebeen C, Chahine D, Caltagirone A, Segal P, and Pantopoulos K. A phosphomimetic mutation at Ser-138 renders iron regulatory protein 1 sensitive to iron-dependent degradation. Mol Cell Biol 23: 6973-6981, 2003.
106. Fillebeen C, Descamps L, Dehouck M-P, Fenart L, Benaïssa M, Spik G, Cecchelli R, and Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274: 7011-7017, 1999.
107. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM Strouse JJ, Markianos K, Andrews NC, and Fleming MD. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40: 569-571, 2008.
108. Finberg KE, Whittlesey RL, Fleming MD, and Andrews NC. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 115: 3817-3826, 2010.
109. Finch C. Regulators of iron balance in humans. Blood 84: 1697-1702, 1994.
110. Fischbach FA, Gregory DW, Harrison PM, Hoy TG, and Williams JM. On the structure of hemosiderin and its relationship to ferritin. J Ultrastruct Res 37: 495-503, 1971.
111. Fischbach MA, Lin H, Liu DR, and Walsh CT. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol 2: 132-138, 2006.
112. Flashman E, Davies SL, Yeoh KK, and Schofield CJ. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem J 427: 135-142, 2010.
113. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, and Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 95: 1148-1153, 1998.
114. Fleming MD, Trenor III CC, Su MA, Foernzler D, Beier DR, Dietrich WF, and Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene p383. Nat Genet 16: 383-386, 1997.
115. Fleming PJ and Kent UM. Cytochrome b561, ascorbic acid, and transmembrane electron transfer. Am J Clin Nutr 54: 1173S-1178S, 1991.
116. Folgueras AR, de Lara FM, Pendás AM, Garabaya C, Ro-dríguez F, Astudillo A, Bernal T, Cabanillas R, López-Otín C, and Velasco G. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112: 2539-2545, 2008.
117. Foot NJ, Dalton HE, Shearwin-Whyatt LM, Dorstyn L, Tan SS, Yang B, and Kumar S. Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood 112: 4268-4275, 2008.
118. Forejtnikova H, Vieillevoye M, Zermati Y, Lambert M, Pellegrino RM, Guihard S, Gaudry M, Camaschella C, La-combe C, Roetto A, Mayeux P, and Verdier F. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood 116: 5357-5367, 2010.
119. Friedlich AL, Tanzi RE, and Rogers JT. The 5¢-untranslated region of Parkinson's disease a-synuclein messenger RNA contains a predicted iron responsive element. Mol Psychiatry 12: 222-231, 2007.
120. Fujisawa H and Okuno S. Regulatory mechanism of tyro-sine hydroxylase activity. Biochem Biophys Res Commun 338: 271-276, 2005.
121. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 117: 4425-4433, 2011.
122. Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 46: 554-557, 2006.
123. Gao J, Chen J, De Domenico I, Koeller DM, Harding CO, Fleming RE, Koeberl DD, and Enns CA. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood 115: 3374-3381, 2010.
124. Ghio AJ, Nozik-Grayck E, Turi J, Jaspers I, Mercatante DR, Kole R, and Piantadosi CA. Superoxide-dependent iron uptake. A new role for anion exchange protein 2. Am J Respir Cell Mol Biol 29: 653-660, 2003.
125. Giannetti AM and Björkman PJ. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. J Biol Chem 279: 25866-25875, 2004.
126. Giannetti AM, Snow PM, Zak O, and Björkman PJ. Mechanism for multiple ligand recognition by the human transferrin receptor. PLoS Biol 1: 341-350, 2003.
127. Girijashanker K, He L, Soleimani M, Reed JM, Li H, Liu Z, Wang B, Dalton TP, and Nebert DW. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol 73: 1413-1423, 2008.
128. Gkouvatsos K, Wagner J, Papanikolaou G, Sebastiani G, and Pantopoulos K. Conditional disruption of mouse Hfe2 gene: Maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin. Hepatology 54: 1800-1807, 2011.
129. Goswami T and Andrews NC. Hereditary hemochroma-tosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281: 28494-28498, 2006.
130. Graham RM, Reutens GM, Herbison CE, Delima RD, Chua AC, Olynyk JK, and Trinder D. Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron. J Hepatol 48: 327-334, 2008.
131. Grant BD and Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 10: 597-608, 2009.
132. Greenberg DA, Jin K, and Khan AA. Neuroglobin: an endogenous neuroprotectant. Curr Opin Pharmacol 8: 20-24, 2008.
133. Greenberg GR and Wintrobe MM. A labile iron pool. J Biol Chem 165: 397-398, 1946.
134. Grogan G. Cytochromes P450: exploiting diversity and enabling application as biocatalysts. Curr Opin Chem Biol 15: 1-8, 2010.
135. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, and Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatog-raphy and nuclear magnetic resonance spectroscopy. J Biol Chem 264: 4417-4422, 1989.
136. Gros G, Wittenberg BA, and Jue T. Myoglobin's old and new clothes: from molecular structure to function in living cells. J Exp Biol 213: 2713-2725, 2010.
137. Guillem F, Lawson S, Kannengiesser C, Westerman M, Beaumont C, and Grandchamp B. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 112: 2089-2091, 2008.
138. Gunshin H, Allerson CR, Polycarpou-Schwarz M, Rofts A, Rogers JT, Kishi F, Hentze MW, Rouault TA, Andrews NC, and Hediger MA. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett 509: 309-316, 2001.
139. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, and Hediger MA. Cloning and characterization of a mammalian protoncoupled metal-ion transporter. Nature 388: 482-488, 1997.
140. Gunshin H, Starr CN, Direnzo C, Fleming MD, Jin J, Greer EL, Sellers VM, Galica SM, and Andrews NC. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 106: 2879-2883, 2005.
141. Guo B, Phillips JD, Yu Y, and Leibold EA. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem 270: 21645-21651, 1995.
142. Gutteridge JM and Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Bio-chem J 256: 861-865, 1988.
143. Haas H, Eisendle M, and Turgeon BG. Siderophores in fungal physiology and virulence. Annu Rev Phytopathol 46: 149-187, 2008.
144. Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299: F1-F13, 2010.
145. Haber F and Weiss J. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc London, Ser A 147: 332-351, 1934.
146. Han O. Molecular mechanism of intestinal iron absorption. Metallomics 3: 103-109, 2011.
147. Harrison PM and Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161-203, 1996.
148. Hellman NE and Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 22: 439-458, 2002.
149. Hentze MW and Kühn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93: 8175-8182, 1996.
150. Hentze MW, Muckenthaler MU, and Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297, 2004.
151. Hentze MW, Muckenthaler MU, Galy B, and Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 142: 24-38, 2010.
152. Hershko C and Peto TE. Non-transferrin plasma iron. Br J Haematol 66: 149-151, 1987.
153. Hershko C, Graham G, Bates GW, and Rachmilewitz E. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. BrJ Haematol 40: 255-263, 1978.
154. Hodges VM, Rainey S, Lappin TR, and Maxwell AP. Pathophysiology of anemia and erythrocytosis. Crit Rev Oncol Hematol 64: 139-158, 2007.
155. Högbom M. Metal use in ribonucleotide reductase R2, di-iron, di-manganese and heterodinuclear-an intricate bioinorganic workaround to use different metals for the same reaction. Metallomics 3: 110-120, 2011.
156. Horowitz MP and Greenamyre JT. Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimer's Dis 20 Suppl 2: S551-S568, 2010.
157. Hrkal Z, Vodrázka Z, and Kalousek I. Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin. Eur J Biochem 43: 73-78, 1974.
158. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, and Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 115: 2187-2191, 2005.
159. Huang ML-H, Lane DJR, and Richardson DR. Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease. Antioxid Redox Signal 15: 3003-3019, 2011.
160. Hubert N and Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A 99: 12345-12350, 2002.
161. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, and Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 75: 102-107, 1990.
162. Hunt S, Green J, and Artymiuk PJ. Hemolysin E (HlyE, ClyA, SheA) and related toxins. Adv Exp Med Biol 677: 116-126, 2010.
163. Hvidberg V, Maniecki MB, Jacobsen C, Højrup P, Møller HJ, and Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106: 2572-2579, 2005.
164. Inman RS and Wessling-Resnick M. Characterization of transferrin- independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake. J Biol Chem 268: 8521-8528, 1993.
165. Ishikawa H, Kato M, Hori H, Ishimori K, Kirisako T, Tokunaga F, and Iwai K. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol Cell 19: 171-181, 2005.
166. 2 sensing. Science 292: 464-468, 2001.
167. Ivanov I, Heydeck D, Hofheinz K, Roffeis J, O'Donnell VB, Kuhn H, and Walther M. Molecular enzymology of lipoxygenases. Arch Biochem Biophys 503: 161-174, 2010.
168. Iwai K, Klausner RD, and Rouault TA. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J 14: 5350-5357, 1995.
169. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
170. Jacobs A. Low-molecular weight intracellular iron transport compounds. Blood 50: 433-439, 1977.
171. Jacolot S, Férec C, and Mura C. Iron responses in hepatic, intestinal and macrophage/monocyte cell lines under different culture conditions. Blood Cells Mol Dis 41: 100-108, 2008.
172. Jeong J and Guerinot ML. Homing in on iron homeostasis in plants. Trends Plant Sci 14: 280-285, 2009.
173. Jeong J, Rouault TA, and Levine RL. Identification of a heme-sensing domain in iron regulatory protein 2. J Biol Chem 279: 45450-45454, 2004.
174. Jing SQ and Trowbridge IS. Identification of the intermo-lecular disulfide bonds of the human transferrin receptor and its lipid-attachment site. EMBO J 6: 327-331, 1987.
175. Johnson MB and Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104: 4287-4293, 2004.
176. Johnson MB, Chen J, Murchison N, Green FA, and Enns CA. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol Biol Cell 18: 743-754, 2007.
177. Jordan I and Kaplan J. The mammalian transferrin-independent iron transport system may involve a surface ferrireductase activity. Biochem J 302: 875-879, 1994.
178. 12, ascorbic acid and iron metabolism in scurvy. Am J Med 40: 119-126, 1966.
179. Kakar S, Hoffman FG, Storz JF, Fabian M, and Hargrove MS. Structure and reactivity of hexacoordinate hemoglobins. Biophys Chem 152: 1-14, 2010.
180. Kakhlon O and Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 33: 1037-1046, 2002.
181. Karin M and Mintz B. Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocar-cinoma stem cells. J Biol Chem 256: 3245-3252, 1981.
182. Kautz L, Besson-Fournier C, Meynard D, Latour C, Roth M-P, and Coppin H. Iron overload induces BMP6 expression in the liver but not in the duodenum. Haematologica 96: 199-203, 2011.
183. Kautz L, Meynard D, Besson-Fournier C, Darnaud V, Al Saati T, Coppin H, and Roth M-P. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood 114: 2515-2520, 2009.
184. Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, and Koeffler HP. Transferrin receptor 2-a supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 275: 16618-16625, 2000.
185. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, and Koeffler HP. Molecular cloning of transferrin receptor 2: A new member of the transferrin receptor-like family. J Biol Chem 274: 20826-20832, 1999.
186. Ke Y, Wu J, Leibold EA, Walden WE, and Theil EC. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation? J Biol Chem 273: 23637-23640, 1998.
187. Kemna EHJM, Tjalsma H, Podust VN, and Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53: 620-628, 2007.
188. This reference has been deleted.
189. Kirkman HN and Gaetani GF. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 32: 44-50, 2007.
190. Knutson MD. Iron-sensing proteins that regulate hepcidin and enteric iron absorption. Annu Rev Nutr 30: 149-171, 2010.
191. Knutson MD, Vafa MR, Haile DJ, and Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102: 4191-4197, 2003.
192. Kohler SA, Henderson BR, and Kühn LC. Succinate dehydrogenase B mRNA of Drosophila melanogaster has a functional iron-responsive element in its 5¢-untranslated region. J Biol Chem 270: 30781-30786, 1995.
193. Kohler SA, Menotti E, and Kühn LC. Molecular cloning of mouse glycolate oxidase. High evolutionary conservation and presence of an iron-responsive element-like sequence in the mRNA. J Biol Chem 274: 2401-2407, 1999.
194. Kolberg M, Strand KR, Graff P, and Andersson KK. Structure, function, and mechanism of ribonucleotide reductases. Biochim Biophys Acta 1699: 1-34, 2004.
195. Königsberger L-C, Königsberger E, May PM, and Hefter GT. Complexation of iron(III) and iron(II) by citrate. Implications for iron speciation in blood plasma. J Inorg Biochem 78: 175-184, 2000.
196. Konijn AM, Glickstein H, Vaisman B, Meyron-Holtz EG, Slotki IN, and Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 94: 2128-2134, 1999.
197. Koorts AM, Levay PF, Hall AN, van der Merwe CF, Becker PJ, and Viljoen M. Expression of the H-subunit and L-subunit of ferritin in bone marrow macrophages and cells of the erythron during cellular immune activation. Blood Cells Mol Dis 47: 50-55, 2011.
198. Koury MJ and Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr 24: 105-131, 2004
199. Krause A, Neitz S, Mägert H-J, Schulz A, Forssmann WG, Schulz-Knappe P, and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147-150, 2000.
200. Kruszewski M. The role of labile iron pool in cardiovascular diseases. Acta Biochim Polon 51: 471-480, 2004.
201. Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, Janetzko A, Cetin Y, and Stremmel W. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184: 361-370, 2005.
202. Kurz T, Eaton JW, and Brunk UT. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol 43: 1686-1697, 2011.
203. Lakhal S, Schödel J, Townsend ARM, Pugh CW, Ratcliffe PJ, and Mole DR. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem 286: 4090-4097, 2011.
204. Lane DJR and Lawen A. Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J Biol Chem 283: 12701-12708, 2008.
205. Lane DJ and Lawen A. Ascorbate and plasma membrane electron transport-enzymes vs efflux. Free Radic Biol Med 47: 485-495, 2009.
206. Lane DJR and Lawen A. Transplasma membrane electron transport comes in two flavors. BioFactors 34: 191-200, 2009.
207. Lane DJR, Robinson SR, Czerwinska H, Bishop GM, and Lawen A. Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem J 432: 123-132, 2010.
208. Lange H, Kispal G, and Lill R. Mechanism of iron transport to the site of heme synthesis inside yeast mitochondria. J Biol Chem 274: 18989-18996, 1999.
209. Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo A-P, Grammatico P, Volinia S, Gasparini P, and Camaschella C. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103: 4317-4321, 2004.
210. Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassú AM, Bonaparte D, Cavalcante MM, Chora A, Ferreira A, Marguti I, Cardoso S, Sepúlveda N, Smith A, and Soares MP. A central role for free heme in the patho-genesis of severe sepsis. Sci Transl Med 2: 51ra71, 2010.
211. Latunde-Dada GO, Simpson RJ, and McKie AT. Duodenal cytochrome B expression stimulates iron uptake by human intestinal epithelial cells. J Nutr 138: 991-995, 2008.
212. Latunde-Dada GO, Van der Westhuizen J, Vulpe CD, Anderson GJ, Simpson RJ, and McKie AT. Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism. Blood Cells Mol Dis 29: 356-360, 2002.
213. Latunde-Dada GO, Xiang L, Simpson RJ, and McKie AT. Duodenal cytochrome b (Cybrd 1) and HIF-2a expression during acute hypoxic exposure in mice. Eur J Nutr 50: 699-704, 2011.
214. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller G, Abu-Asab M, Tsokos M, Switzer R III, Grinberg A, Love P, Tresser N, and Rouault TA. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27: 209-214, 2001.
215. Lawrence CM, Ray S, Babyonyshev M, Galluser R, Borhani DW, and Harrison SC. Crystal structure of the ectodomain of human transferrin receptor. Science 286: 779-782, 1999.
216. Layer G, Jahn D, and Jahn M. Heme biosynthesis. In: Handbook of Porphyrin Science with Applications to Chemistry, Physics, Materials Science, Engineering, Biology and Medicine, Volume 15. Edited by Kadish KM, Smith KM, and Guilard R. Hacksack NJ, London, Singapore: World Scientific Publishing Co. Pte. Ltd., 2011, pp. 159-215.
217. Lee D-H, Zhou L-J, Zhou Z, Xie J-X, Jung J-U, Liu Y, Xi C-X, Mei L, and Xiong W-C. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood 115: 3136-3145, 2010.
218. Lee FS and Percy MJ. The HIF pathway and erythrocytosis. Annu Rev Pathol 6: 165-192, 2011.
219. 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 101: 9263-9265, 2004.
220. Leimberg MJ, Prus E, Konijn AM, and Fibach E. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem 103: 1211-1218, 2008.
221. Lenoir A, Deschemin J-C, Kautz L, Ramsay AJ, Roth M-P, Lopez-Otin C, Vaulont S, and Nicolas G. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Blood 117: 647-650, 2011.
222. Lesbordes-Brion J-C, Viatte L, Bennoun M, Lou D-Q, Ramey G, Houbron C, Hamard G, Kahn A, and Vaulont S. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108: 1402-1405, 2006.
223. Lesnikov V, Gorden N, Fausto N, Spaulding E, Campbell J, Shulman H, Fleming RE, and Deeg HJ. Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2. Apoptosis 13: 1005-1012, 2008.
224. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, and Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276: 24437-24440, 2001.
225. Levy JE, Jin O, Fujiwara Y, Kuo F, and Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21: 396-399, 1999.
226. Li R-c, Saleem S, Zhen G, Cao W, Zhuang H, Lee J, Smith A, Altruda F, Tolosano E, and Doré S. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab 29: 953-964, 2009.
227. Li Z, Lai Z, Ya K, Fang D, Ho YW, Lei Y, and Ming QZ. Correlation between the expression of divalent metal transporter 1 and the content of hypoxia-inducible factor-1 in hypoxic HepG2 cells. J Cell Mol Med 12: 569-579, 2008.
228. Liang X, Lin T, Sun G, Beasley-Topliffe L, Cavaillon JM, and Warren HS. Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J Leukoc Biol 86: 229-235, 2009.
229. Lin L, Goldberg YP, and Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuve-lin. Blood 106: 2884-2889, 2005.
230. Liuzzi JP, Aydemir F, Nam H, Knutson MD, and Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A 103: 13612-13617, 2006.
231. Loenarz C and Schofield CJ. Expanding chemical biology of 2-oxoglutarate oxygenases. Nat Chem Biol 4: 152-156, 2008.
232. Lok CN and Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 274: 24147-24152, 1999.
233. Ludwiczek S, Aigner E, Theurl I, and Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101: 4148-4154, 2003.
234. Ly JD and Lawen A. Transplasma membrane electron transport: enzymes involved and biological function. Redox Rep 8: 3-21, 2003.
235. Lynch RE and Fridovich I Permeation of the erythrocyte stroma by superoxide radical. J Biol Chem 253: 4697-4699, 1978.
236. Ma Y, Yeh M, Yeh KY, and Glass J. Iron Imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 290: G417-G422, 2006.
237. 2+ transport and uncoupled fluxes. Pflü gers Arch Eur J Physiol 451: 544-558, 2006.
238. Magro G, Cataldo I, Amico P, Torrisi A, Vecchio GM, Parenti R, Asioli S, Recupero D, D'Agata V, Mucignat MT, and Perris R. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid 21: 267-277, 2011.
239. Makino M, Sawai H, Shiro Y, and Sugimoto H. Crystal structure of the carbon monoxide complex of human cytoglobin. Proteins 79: 1143-1153, 2011.
240. Malecki EA, Devenyi AG, Beard JL, and Connor JR, Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res 56: 113-122, 1999.
241. +-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol 20: 415-426, 2008.
242. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, and Peyssonnaux C. HIF-2a, but not HIF-1a, promotes iron absorption in mice. J Clin Invest 119: 1159-1166, 2009.
243. Matthes S, Mosienko V, Bashammakh S, Alenina N, and Bader M. Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology 85: 95-109, 2010.
244. Mauk MR, Smith A, and Mauk AG. An alternative view of the proposed alternative activities of hemopexin. Protein Sci 20: 791-805, 2011.
245. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent prote-olysis. Nature 399: 271-275, 1999.
246. May JM, Qu Zc, and Mendiratta S. Role of ascorbic acid in transferrin-independent reduction and uptake of iron by U-937 cells. Biochem Pharmacol 57: 1275-1282, 1999.
247. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, and Simpson RJ. A novel duodenal iron regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309, 2000.
248. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, and Simpson RJ. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291: 1755-1759, 2001.
249. Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, Westerman M, Cazzola M, and Galanello R. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 93: 1473-1479, 2008.
250. Merle U, Fein E, Gehrke SG, Stremmel W, and Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 148: 2663-2668, 2007.
251. 12 or folate deficiency does not translate into a comparable prevalence of anemia. Food Nutr Bull 29: S74-S85, 2008.
252. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, and Roth M-P. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41: 478-481, 2009.
253. Meyron-Holtz EG, Ghosh MC, and Rouault TA. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306: 2087-2090, 2004.
254. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Braz-zolotto X, Berger UV, Land W, Ollivierre-Wilson H, Grin-berg A, Love P, and Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23: 386-395, 2004.
255. Mick DU, Fox TD, and Rehling P. Inventory control: cyto-chrome c oxidase assembly regulates mitochondrial translation. Nat Rev Mol Cell Biol 12: 14-20, 2011.
256. Milet J, Le Gac G, Scotet V, Gourlaouen I, Thèze C, Mosser J, Bourgain C, Deugnier Y, and Férec C. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study. Blood Cells Mol Dis 44: 34-37, 2010.
257. Milman N. Anemia-still a major health problem in many parts of the world! Ann Hematol 90: 369-377, 2011.
258. 561, in the reduction of ferric ions. J Biochem 142: 699-705, 2007.
259. Mole DR. Iron homeostasis and its interaction with prolyl hydroxylases. Antioxid Redox Signal 12: 445-458, 2010.
260. Moos T. Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375: 675-692, 1996.
261. Moos T and Morgan EH. Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20: 77-95, 2000.
262. Moos T and Morgan EH. A morphological study of the developmentally regulated transport of iron into the brain. Dev Neurosci 24: 99-105, 2002.
263. Moos T, Nielsen TR, Skjørringe T, and Morgan EH. Iron trafficking inside the brain. J Neurochem 103: 1730-1740, 2007.
264. Morgan EH. Transferrin, biochemistry, physiology and clinical significance. Molec Asp Med 4: 1-123, 1981.
265. Morgan EH. Mechanisms of iron transport into rat erythroid cells. J Cell Physiol 186: 193-200, 2001.
266. Moroo I, Ujiie M, Walker BL, Tiong JWC, Vitalis TZ, Karkan D, Gabathuler R, Moise AR, and Jefferies WA. Identification of a novel route of iron transcytosis across the mammalian blood-brain barrier. Microcirculation 10: 457-462, 2003.
267. Muckenthaler MU, Galy B, and Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 28: 197-213, 2008.
268. Mukhopadhyay CK, Mazumder B, and Fox PL. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 275: 21048-21054, 2000.
269. Müllner EW and Kühn LC. A stem-loop in the 3¢ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53: 815-825, 1988.
270. Muñoz M, Garćia-Erce JA, and Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homo-eostasis. J Clin Pathol 64: 281-286, 2011.
271. Musílková J, Kriegerbecková K, Krù sek J, and Kovár J. Specific binding to plasma membrane is the first step in the uptake of nontransferrin iron by cultured cells. Biochim Biophys Acta 1369: 103-108, 1998.
272. Nairz M and Weiss G. Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis. Wien Klin Wochenschr 118: 442-462, 2006.
273. Neckers LM and Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci U S A 80: 3494-3498, 1983.
274. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276, 2004.
275. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
276. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grand-champ B, Kahn A, and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98: 8780-8785, 2001.
277. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044, 2002.
278. Niederkofler V, Salie R, and Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 115: 2180-2186, 2005.
279. Nielsen MJ, Møller HJ, and Moestrup SK. Hemoglobin and heme scavenger receptors. Antioxid Redox Signal 12: 261-273, 2010.
280. Núñez M-T, Gaete V, Watkins JA, and Glass J. Mobilization of iron from endocytic vesicles. The effects of acidification and reduction. J Biol Chem 265: 6688-6692, 1990.
281. Nytko KJ, Maeda N, Schläfli P, Spielmann P, Wenger RH, and Stiehl DP. Vitamin C is dispensable for oxygen sensing in vivo. Blood 117: 5485-5493, 2011.
282. O'Connell M, Halliwell B, Moorhouse CP, Aruoma OI, Baum H, and Peters TJ. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism? Biochem J 234: 727-731, 1986.
283. Octave J-N, Schneider Y-J, Hoffmann P, Trouet A, and Crichton RR. Transferrin protein and iron uptake by cultured rat fibroblasts. FEBS Lett 108: 127-130, 1979.
284. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, and Fleming MD. Identification of a ferrireductase required for efficient transferrin dependent iron uptake in erythroid cells. Nat Genet 37: 1264-1269, 2005.
285. Ozer A and Bruick RK. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol 3: 144-153, 2007.
286. Pantopoulos K. Function of the hemochromatosis protein HFE: lessons from animal models. World J Gastroenterol 14: 6893-6901, 2008.
287. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald MIE, Franchini PL, Dubé M-P, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, and Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemo-chromatosis. Nat Genet 36: 77-82, 2004.
288. Pappalardi MB, McNulty DE, Martin JD, Fisher KE, Jiang Y, Burns MC, Zhao H, Ho T, Sweitzer S, Schwartz B, Annan RS, Copeland RA, Tummino PJ, and Luo L. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites. Biochem J 436: 363-369, 2011.
289. Park CH, Valore EV, Waring AJ, and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001.
290. Pelizzoni I, Zacchetti D, Smith CP, Grohovaz F, and Codazzi F. Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J Neurochem 120: 269-278, 2012.
291. Peslova G, Petrak J, Kuzelova K, Hrdy I, Halada P, Kuchel PW, Soe-Lin S, Ponka P, Sutak R, Becker E, Huang ML-H, Rahmanto YS, Richardson DR, and Vyoral D. Hepcidin, the hormone of iron metabolism, is bound specifically to a-2-macroglobulin in blood. Blood 113: 6225-6236, 2009.
292. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, Nizet V, and Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 117: 1926-1932, 2007.
293. Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 54: 173-181, 2011.
294. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, and Loréal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819, 2001.
295. Pinilla-Tenas JJ, Sparkman BK, Shawki A, Illing AC, Mitchell CJ, Zhao N, Liuzzi JP, Cousins RJ, Knutson MD, and Mackenzie B. Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. Am J Physiol Cell Physiol 301: C862-C871, 2011.
296. Piperno A, Mariani R, Trombini P, and Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 15: 538-551, 2009.
297. Pitula JS, Deck KM, Clarke SL, Anderson SA, Vasantha-kumar A, and Eisenstein RS. Selective inhibition of the citrate-to-isocitrate reaction of cytosolic aconitase by phos-phomimetic mutation of serine-711. Proc Natl Acad Sci U S A 101: 10907-10912, 2004.
298. Poli M, Luscieti S, Gandini V, Maccarinelli F, Finazzi D, Silvestri L, Roetto A, and Arosio P. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica 95: 1832-1840, 2010.
299. Polla BS. Therapy by taking away: the case of iron. Biochem Pharmacol 57: 1345-1349, 1999.
300. Presley JF, Mayor S, McGraw TE, Dunn KW, and Maxfield FR. Bafilomycin A1 treatment retards transferrin receptor recycling more than bulk membrane recycling. J Biol Chem 272: 13929-13936, 1997.
301. Qian Z-M, Wu XM, Fan M, Yang L, Du F, Yung W-H, and Ke Y. Divalent metal transporter 1 is a hypoxia-inducible gene. J Cell Physiol 226: 1596-1603, 2001.
302. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, and Goldman ID. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127: 917-928, 2006.
303. Raffin SB, Woo CH, Roost KT, Price DC, and Schmid R. Intestinal absorption of hemoglobin iron-heme cleavage by mucosal heme oxygenase. J Clin Invest 54: 1344-1352, 1974.
304. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, and Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 1790: 671-681, 2009.
305. Ramey G, Deschemin JC, and Vaulont S. Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 94: 765-772, 2009.
306. Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, Roth M-P, Nemeth E, and Ganz T. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53: 1333-1341, 2011.
307. Reardon TF and Allen DG Time to fatigue is increased in mouse muscle at 37°C; the role of iron and reactive oxygen species. J Physiol 587: 4705-4716, 2009.
308. Recalcati S, Minotti G, and Cairo G Iron regulatory proteins: from molecular mechanisms to drug development. Antioxid Redox Signal 13: 1593-1616, 2010.
309. Rhodes SL and Ritz B. Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis 32: 183-195, 2008.
310. Richardson DR and Morgan EH. The transferrin homologue, melanotransferrin (p97), is rapidly catabolized by the liver of the rat and does not effectively donate iron to the brain. Biochim Biophys Acta 1690: 124-133, 2004.
311. Richardson DR, Kalinowski DS, Lau S, Jansson PJ, and Lovejoy DB. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 1790: 702-717, 2009.
312. Richardson DR, Lane DJR, Becker EM, Huang ML, Whitnall M, Suryo Rahmanto Y, Sheftel AD, and Ponka P. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 107: 10775-10782, 2010.
313. Robb A and Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104: 4294-4299, 2004.
314. Rochette J, Le Gac G, Lassoued K, Férec C, and Robson KJ. Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum Genet 128: 233-248, 2010.
315. Roetto A, Totaro A, Cazzola M, Cicilano M, Bosio S, D'Ascola G, Carella M, Zelante L, Kelly AL, Cox TM, Gasparini P, and Camaschella C. Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 64: 1388-1393, 1999.
316. Rolfs A, Kvietikova I, Gassmann M, and Wenger RH. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 272: 20055-20062, 1997.
317. Roos PH and Jakubowski N. Cytochromes-fascinating molecular machines. Metallomics 3: 316-318, 2011.
318. Roth JA, Singleton S, Feng J, Garrick M, and Paradkar PN. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. J Neurochem 113: 454-464, 2010.
319. Rouault TA and Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 13: 142-148, 2006.
320. Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2: 406-414, 2006.
321. Roy CN and Enns CA. Iron homeostasis: new tales from the crypt. Blood 96: 4020-4027, 2000.
322. Ryan JD, Ryan E, Fabre A, Lawless MW, and Crowe J. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Hepatology 52: 1266-1273, 2010.
323. Saha R, Saha N, Donofrio RS, and Bestervelt LL. Microbial siderophores: a mini review. J Basic Microbiol 2012 [Epub ahead of print]; DOI: 10.1002/jobm.201100552.
324. Salahudeen AA, Thompson JW, Ruiz JC, Ma H-W, Kinch LN, Li Q, Grishin NV, and Bruick RK. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326: 722-726, 2009.
325. Sammarco MC, Ditch S, Banerjee A, and Grabczyk E. Ferritin L and H subunits are differentially regulated on a post-transcriptional level. J Biol Chem 283: 4578-4587, 2008.
326. Sanchez M, Galy B, Dandekar T, Bengert P, Vainshtein Y, Stollte J, Muckenthaler MU, and Hentze MW. Iron regulation and the cell cycle: Identification of an iron-responsive element in the 3¢ untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy. J Biol Chem 281: 22865-22874, 2006.
327. Sanchez M, Galy B, Muckenthaler MU, and Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2a expression in iron deficiency. Nat Struct Mol Biol 14: 420-426, 2007.
328. Schalinske KL, Chen OS, and Eisenstein RS. Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. Implications for iron regulatory proteins as regulators of mitochondrial citrate utilization. J Biol Chem 273: 3740-3746, 1998.
329. Schalk IJ, Hannauer M, and Braud A. New roles for bacterial siderophores in metal transport and tolerance. Environ Microbiol 13: 2844-2854, 2011.
330. Scheers NM and Sandberg A-S. Ascorbic acid uptake affects ferritin, Dcytb and Nramp2 expression in Caco-2 cells. Eur J Nutr 47: 401-408, 2008.
331. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, and Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 7: 205-214, 2008.
332. Sekyere EO, Dunn LL, Rahmanto YS, and Richardson DR. Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivo. Blood 107: 2599-2601, 2006.
333. Shah YM, Matsubara T, Ito S, Yim SH, and Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 9: 152-164, 2009.
334. 6, and polymorphisms. Food Nutr Bull 29: S5-S16, 2008.
335. Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, Gwynn B, Lambert AJ, Wingert RA, Traver D, Trede NS, Barut BA, Zhou Y, Minet E, Donovan A, Brownlie A, Balzan R, Weiss MJ, Peters LL, Kaplan J, Zon LI, and Paw BH. Mitoferrin is essential for erythroid iron assimilation. Nature 440: 96-100, 2006.
336. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, and McKie AT. Identification of an intestinal heme transporter. Cell 122: 789-801, 2005.
337. Sheftel AD and Lill R. The power plant of the cell is also a smithy: the emerging role of mitochondria in cellular iron homeostasis. Ann Med 41: 82-99, 2009.
338. Sheftel AD, Kim SF, and Ponka P. Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism. J Biol Chem 282: 10480-10486, 2007.
339. Sheftel A, Stehling O, and Lill R. Iron-sulfur proteins in health and disease. Trends Endocrinol Metab 21: 302-314, 2010.
340. Sheftel AD, Zhang AS, Brown C, Shirihai OS, and Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110: 125-132, 2007.
341. Shi H, Bencze KZ, Stemmler TL, and Philpott CC. A cyto-solic iron chaperone that delivers iron to ferritin. Science 320: 1207-1210.
342. Shi Y and Massague J. Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003.
343. Shih YJ, Baynes RD, Hudson BG, Flowers CH, Skikne BS, and Cook JD. Serum transferrin receptor is a truncated form of tissue receptor. J Biol Chem 265: 19077-19081, 1990.
344. Shvartsman M, Kikkeri R, Shanzer A, and Cabantchik ZI. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications. Am J Physiol Cell Physiol 293: C1383-C1394, 2007.
345. Siddique A and Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther 35: 876-893, 2012.
346. Silvestri L, Pagani A, and Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111: 924-931, 2008.
347. Silvestri L, Pagani A, Fazi C, Gerardi G, Levi S, Arosio P, and Camaschella C. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 109: 4503-4510, 2007.
348. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, and Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8: 502-511, 2008.
349. Simpson RJ and McKie AT. Regulation of intestinal iron absorption: the mucosa takes control? Cell Metab 10: 84-87, 2009.
350. Singh AK, Singh N, Sinha M, Bhushan A, Kaur P, Srinivasan A, Sharma S, and Singh TP. Binding modes of aromatic ligands to mammalian heme peroxidases with associated functional implications: crystal structures of lactoperoxidase complexes with acetylsalicylic acid, sali-cylhydroxamic acid, and benzylhydroxamic acid. J Biol Chem 284: 20311-20318, 2009.
351. Skaar EP. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 6: e1000949, 2010.
352. Skikne BS, Flowers CH, and Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75: 1870-1876, 1990.
353. Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, and Southwick PC. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol 86: 923-927, 2011.
354. Smith A. Links between cell-surface events involving redox-active copper and gene regulation in the hemopexin heme transport system. Antioxid Redox Signal 2: 157-175, 2000.
355. Smith A. Mechanisms of cytoprotection by hemopexin. In: Handbook of Porphyrin Science with Applications to Chemistry, Physics, Materials Science, Engineering, Biology and Medicine, Volume 15. Edited by Kadish KM, Smith KM, and Guilard R. Hacksack NJ, London, Singapore: World Scientific Publishing Co. Pte. Ltd., 2011, pp. 217-355.
356. Smith A and Hunt RC. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. Eur J Cell Biol 53: 234-245, 1990.
357. Smith A and Morgan WT. Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. Biochem J 182: 47-54, 1979.
358. Smith A and Morgan WT. Transport of heme by hemo-pexin to the liver: evidence for receptor-mediated uptake. Biochem Biophys Res Commun 84: 151-157, 1978.
359. Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R III, Messing A, and Rouault TA. Severity of neurodegen-eration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann N Y Acad Sci 1012: 65-83, 2004.
360. Soe-Lin S, Apte SS, Andriopoulos B, Jr., Andrews MC, Schranzhofer M, Kahawita T, Garcia-Santos D, and Ponka P. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci U S A 106: 5960-5965, 2009.
361. Soe-Lin S, Apte SS, Mikhael MR, Kayembe LK, Nie G, and Ponka P. Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling. Exp Hematol 38: 609-617, 2010.
362. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, and Gouaux JE. Structure of Staphyloccal a-hemolysin, a hep-tameric transmembrane pore. Science 274: 1859-1866, 1996.
363. Stadtman ER. Ascorbic acid and oxidative inactivation of proteins. Am J Clin Nutr 54(6 Suppl): 1125S-1128S, 1991.
364. Stassen FL, Cardinale GJ, and Udenfriend S. Activation of prolyl hydroxylase in L-929 fibroblasts by ascorbic acid. Proc Natl Acad Sci U S A 70: 1090-1093, 1973.
365. Steinbicker AU, Bartnikas TB, Lohmeyer LK, Leyton P, Mayeur C, Kao SM, Pappas AE, Peterson RT, Bloch DB, Yu PB, Fleming MD, and Bloch KD. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood 118: 4224-4230, 2011.
366. Stoltzfus R. Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr 131: 565S-567S, 2001.
367. 561 are ascorbate-dependent ferrireductases. FEBS J 273: 3722-3734, 2006.
368. Su MA, Trenor CC, Fleming JC, Fleming MD, and Andrews NC. The G185R mutation disrupts function of the iron transporter Nramp2. Blood 92: 2157-2163, 1998.
369. Tacchini L, Bianchi L, Bernelli-Zazzera A, and Cairo G. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcrip-tional regulation. J Biol Chem 274: 24142-24146, 1999.
370. Taher AT, Musallam KM, Cappellini MD, and Weatherall DJ. Optimal management of b thalassaemia intermedia. Br J Haematol 152: 512-523, 2011.
371. Takahashi N, Takahashi Y, and Putnam FW. Complete amino acid sequence of human hemopexin, the heme-binding protein of serum. Proc Natl Acad Sci U S A 82: 73-77, 1985.
372. Talukder MJR, Takeuchi T, and Harada E. Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. J Vet Med Sci 65: 957-964, 2003.
373. Tanno T and Miller JL. Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol 2010: Article ID 358283, 2010.
374. Taurog A. Molecular evolution of thyroid peroxidase. Biochimie 81: 557-562, 1999.
375. Theil EC and Goss DJ. Living with iron (and oxygen): questions and answers about iron homeostasis. Chem Rev 109: 4568-4579, 2009.
376. Theil EC. Iron homeostasis and nutritional iron deficiency. J Nutr 141: 724S-728S, 2011.
377. Theil EC. Targeting mRNA to regulate iron and oxygen metabolism. Biochem Pharmacol 59: 87-93, 2000.
378. Theurl I, Schroll A, Sonnweber T, Nairz M, Theurl M, Willenbacher W, Eller K, Wolf D, Seifert M, Sun CC, Babitt JL, Hong CC, Menhall T, Gearing P, Lin HY, and Weiss G. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic disease in rats. Blood 118: 4977-4984, 2011.
379. Tolosano E and Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 21: 297-306, 2002.
380. Torti FM and Torti SV. Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
381. Toth I and Bridges KR. Ascorbic acid enhances ferritin mRNA translation by an IRP/aconitase switch. J Biol Chem 270: 19540-19544, 1995.
382. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, and Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90: 4979-4986, 1997.
383. Trinder D, Morgan E, and Baker E. The mechanisms of iron uptake by fetal rat hepatocytes in culture. Hepatology 6: 852-858, 1986.
384. Trinder D, Olynyk JK, Sly WS, and Morgan EH. Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc Natl Acad Sci U S A 99: 5622-5626, 2002.
385. Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giar-dina PJ, Boskey AL, and Vogiatzi MG. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116: 2582-2589, 2010.
386. Tsunoo H and Sussman HH. Characterization of transferrin binding and specificity of the placental transferrin receptor. Arch Biochem Biophys 225: 42-54, 1983.
387. Tulpule K, Robinson SR, Bishop GM, and Dringen R. Uptake of ferrous iron by cultured rat astrocytes. J Neurosci Res 88: 563-571, 2010.
388. Vanoaica L, Darshan D, Richman L, Schümann K, and Kühn LC. Intestinal ferritin H is required for an accurate control of iron absorption. Cell Metab 12: 273-282, 2010.
389. Vargas JD, Herpers B, McKie AT, Gledhill S, McDonnell J, van den Heuvel M, Davies KE, and Ponting CP. Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochim Biophys Acta 1651: 116-123, 2003.
390. Velasco G, Cal S, Quesada V, Sánchez LM, and López- Otín C. Matriptase-2, a membrane-bound mosaic serine pro-teinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 277: 37637-37646, 2002.
391. Velkov T and Lawen A. Nonribosomal peptide synthetases as technological platforms for the synthesis of highly modified peptide bioeffectors-cyclosporin synthetase as a complex example. Biotechnol Annu Rev 9, 151-197, 2003.
392. Verga Falzacappa MV, Casanovas G, Hentze MW, and Muckenthaler MU. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med (Berl) 86: 531-540, 2008.
393. Vinchi F, Gastaldi S, Silengo L, Altruda F, and Tolosano E. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 173: 289-299, 2008.
394. Visca P, Imperi F, and Lamont IL. Pyoverdine side-rophores: from biogenesis to biosignificance. Trends Mi-crobiol 15: 22-30, 2007
395. Volke M, Gale DP, Maegdefrau U, Schley G, Klanke B, Bosserhoff AK, Maxwell PH, Eckardt KU, and Warnecke C. Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-induc-ible factors. PLoS One 4: e7875, 2009.
396. Volz K. The functional duality of iron regulatory protein 1. Curr Opin Struct Biol 18: 106-111, 2008.
397. Vujic Spasić M, Kiss J, Herrmann T, Galy B, Martinache S, Stolte J, Gröne H-J, Stremmel W, Hentze MW, and Muckenthaler MU. Hfe acts in hepatocytes to prevent hemo-chromatosis. Cell Metab 7: 173-178, 2008.
398. Vujic Spasic M, Kiss J, Herrmann T, Kessler R, Stolte J, Galy B, Rathkolb B, Wolf E, Stremmel W, Hentze MW, and Muckenthaler MU. Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood 109: 4511-4517, 2007.
399. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, and Anderson GJ. Hephaestin, a ce-ruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21: 195-199, 1999.
400. Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S, Britton RS, Bacon BR, and Sly WS. Association of HFE protein with transferrin receptor in crypt en-terocytes of human duodenum. Proc Natl Acad Sci U S A 96: 1579-1584, 1999.
401. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, and Subramaniam VN. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50: 1992-2000, 2009.
402. Wallander ML, Leibold EA, and Eisenstein RS. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta 1763: 668-689, 2006.
403. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, and Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with b-thalassaemia or sickle cell disease. Br J Hae-matol 135: 254-263, 2006.
404. Wang J and Slungaard A. Role of eosinophil peroxidase in host defense and disease pathology. Arch Biochem Biophys 445: 256-260, 2006.
405. Wang J, Chen G, Filebeen C, and Pantopoulos K. Insights on regulation and function of the iron regulatory protein 1 (IRP1). Hemoglobin 32: 109-115, 2008.
406. Wang J, Chen G, Muckenthaler M, Galy B, Hentze MW, and Pantopoulos K. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol Cell Biol 24: 954-965, 2004.
407. Wang J, Fillebeen C, Chen G, Biederbick A, Lill R, and Pantopoulos K. Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway. Mol Cell Biol 27: 2423-2430, 2007.
408. Wang R-H, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, Cooper-man S, Eckhaus M, Rouault T, Mishra L, and Deng C-X. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2: 399-409, 2005.
409. Wang W, Di X, D'Agostino RB, Jr., Torti SV, and Torti FM. Excess capacity of the iron regulatory protein system. J Biol Chem 282: 24650-24659, 2007.
410. Watkins JA, Altazan JD, Elder P, Li C-Y, Nunez M-T, Cui X-X, and Glass J. Kinetic characterization of reductant dependent processes of iron mobilization from endocytic vesicles. Biochemistry 31: 5820-5830, 1992.
411. Weatherall DJ. Pathophysiology of thalassaemia. Baillieres Clin Haematol 11: 127-146, 1998.
412. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 1790: 682-693, 2009.
413. Weiss G and Goodnough LT. Anemia of chronic disease. N Engl J Med 352: 1011-1023, 2005.
414. West AP, Jr., Giannetti AM, Herr AB, Bennett MJ, Nangi-ana JS, Pierce JR, Weiner LP, Snow PM, and Bjorkman PJ. Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J Mol Biol 313: 385-397, 2001.
415. Wiesener MS, Jü rgensen JS, Rosenberger C, Scholze CK, Hörstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, and Eckardt K-U. Widespread hypoxia-inducible expression of HIF-2a in distinct cell populations of different organs. FASEB J 17: 271-273, 2003.
416. Winterbourn CC, Vissers MC, and Kettle AJ. Myeloperox-idase. Curr Opin Hematol 7: 53-58, 2000.
417. Wood MJ, Skoien R, and Powell LW. The global burden of iron overload. Hepatol Int 3: 434-444, 2009.
418. Wyllie JC and Kaufman N. An electron microscopic study of heme uptake by rat duodenum. Lab Invest 47: 471-476, 1982.
419. Yamanaka K, Ishikawa H, Megumi Y, Tokunaga F, Kanie M, Rouault TA, Morishima I, Minato N, Ishimori K, and Iwai K. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat Cell Biol 5: 336-340, 2003.
420. Yang L, Fan M, Du F, Gong Q, Bi ZG, Zhu ZJ, Zhu LL, and Ke Y. Hypoxic preconditioning increases iron transport rate in astrocytes. Biochim Biophys Acta 1822: 500-508, 2012.
421. Ye H and Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 49: 4945-4956, 2010.
422. Young GA and Hill GL. Assessment of protein-calorie malnutrition in surgical patients from plasma proteins and anthropometric measurements. Am J Clin Nutr 31: 429-435, 1978.
423. Young SP, Roberts S, and Bomford A. Intracellular processing of transferrin and iron by isolated rat hepatocytes. Biochem J 232: 819-823, 1985.
424. Yu Y, Kovacevic Z, and Richardson DR. Tuning cell cycle regulation with an iron key. Cell Cycle 6: 1982-1994, 2007.
425. Zanella I, Derosas M, Corrado M, Cocco E, Cavadini P, Biasiotto G, Poli M, Verardi R, and Arosio P. The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Biochim Biophys Acta 1782: 90-98, 2008.
426. Zhang A-S, Canonne-Hergaux F, Gruenheid S, Gros P, and Ponka P. Use of Nramp2-transfected Chinese hamster ovary cells and reticulocytes from mk/mk mice to study iron transport mechanisms. Exp Hematol 36: 1227-1235, 2008.
427. Zhang A-S, Yang F, Meyer K, Hernandez C, Chapman-Arvedson T, Bjorkman PJ, and Enns CA. Neogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membrane. J Biol Chem 283: 17494-17502, 2008.
428. Zhang AS and Enns CA. Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem 284: 711-715, 2009.
429. Zhang A-S, Davies PS, Carlson HL, and Enns CA. Mechanisms of HFE-induced regulation of iron homeostasis: insights from the W81A HFE mutation. Proc Natl Acad Sci U S A 100: 9500-9505, 2003.
430. Zhang A-S, West AP, Jr., Wyman AE, Bjorkman PJ, and Enns CA. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem 280: 33885-33894, 2005.
431. Zhang A-S, Yang F, Wang J, Tsukamoto H, and Enns CA. Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression. J Biol Chem 284: 22580-22589, 2009.
432. Zhang X and Rovin BH. Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta 1800: 1262-1267, 2010.
433. Zhao N, Gao J, Enns CA, and Knutson MD. ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin. J Biol Chem 285: 32141-32150, 2010.
434. Zheng L, Kennedy MC, Blondin GA, Beinert H, and Zalkin H. Binding of cytosolic aconitase to the iron responsive element of porcine mitochondrial aconitase mRNA. Arch Biochem Biophys 299: 356-360, 1992.
435. Zimmer M, Ebert BL, Neil C, Brenner K, Papaioannou I, Melas A, Tolliday N, Lamb J, Pantopoulos K, Golub T, and Iliopoulos O. Small-molecule inhibitors of HIF-2a translation link its 5¢UTR iron-responsive element to oxygen sensing. Mol Cell 32: 838-848, 2008.